KELLYE WORTH HALL
Allopathic & Osteopathic Physicians|Emergency Medicine CHARLOTTE, NC NPI 1154463370
Browse related groups: Allopathic & Osteopathic Physicians|Emergency Medicine NC Boehringer Ingelheim Pharmaceuticals, Inc. All categories
General Payments — all program years on this page
$114.82
- Category: General Payments
- Program years: PY2019
- Record count: 8
- As of (CMS publication): 2026-01-23
Latest program year (PY2019): $114.82 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2019) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $114.82 | 8 |
By paying entity
Latest program year (PY2019) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $27.43 | 2 |
| Novo Nordisk AS | $23.54 | 2 |
| Ethicon US, LLC | $19.06 | 1 |
| Genentech USA, Inc. | $16.46 | 1 |
| EISAI INC. | $14.21 | 1 |
| Janssen Pharmaceuticals, Inc | $14.12 | 1 |
By program year
| Program year | Amount | Records |
|---|---|---|
| 2019 | $114.82 | 8 |
Records — PY2019 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 648713931 | Ethicon US, LLC | $19.06 | 11/22/2019 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 658684587 | Janssen Pharmaceuticals, Inc | $14.12 | 12/11/2019 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 674558413 | Novo Nordisk Inc | $11.36 | 09/17/2019 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 674693743 | Novo Nordisk Inc | $12.18 | 11/21/2019 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 681355147 | Genentech USA, Inc. | $16.46 | 10/30/2019 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 697032515 | EISAI INC. | $14.21 | 09/16/2019 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 700265919 | Boehringer Ingelheim Pharmaceuticals, Inc. | $15.92 | 08/29/2019 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 700265921 | Boehringer Ingelheim Pharmaceuticals, Inc. | $11.51 | 11/22/2019 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2019_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.